MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059980 A) filed by Noida Institute Of Engineering Technology Pharmacy Institute on May 12, 2026, for A Sustained Release Ocular Drug Insert.
Inventors include Pakhi Chakraborty; and Soumya Mishra Tripathi.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: A sustained release ocular drug insert is disclosed for placement in the conjunctival sac. The insert comprises a drug reservoir core containing an ophthalmically active agent, a release controlling membrane, a hydrated ocular contact layer, a peripheral retention edge, and a handling tab region. The membrane regulates diffusion of the agent into tear fluid, while the contact layer improves comfort during blinking. The insert maintains dimensional stability after hydration and provides prolonged local drug availability with reduced need for repeated eye drop administration.
Disclaimer: Curated by HT Syndication.
